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Inhibition of the carbachol-evoked synthesis of inositol phosphates 
by ototoxic drugs in the rat cochlea 
Sylvain Bartolami, Myriam Planche and R&my Pujol 
INSERM U 254 and Uni~~er.site’ de Montpellier II, Lahoratoire de Neurohiologie de I’Audition, Montprlliw, Franw 
(Received 24 July 1992; Revision received 22 January 1993; Accepted 26 January 1993) 
The ability of amikacin, neomycin, ethacrynate, mercuric chloride and cisplatin to alter the inositol phosphate (IP) signalling pathway was 
assessed in the 12-day-old rat cochlea, where the turnover of IPs is coupled to muscarinic receptors. This study was motivated by: (1) the 
demonstration of neomycin binding to phosphatidylinositol 4,Sbiphosphate, the precursor of IPs, and (2) the fact that ototoxic drugs induce 
some common symptoms in outer hair cells. At concentrations below 1 mM, none of the compounds changed the control ‘H-IP formation. 
Mercuric chloride, cisplatin and ethacrynate inhibited the carbachol-induced formation of IPs in a dose-dependent manner with IC?,, values of 
74, 340 and 430 /LM. respectively. The aminoglycosides were less efficient in reducing the carbachol-stimulated accumulation of IPs, since neither 
amikacin nor neomycin. both at 1 mM, had any significant effect. However. neomycin applied at 15 and 30 PM induced 29% and 43% of 
inhibition of the stimulated IP response. Finally, additive effects are obtained between some of the toxic drugs. The results suggest that a block of 
the IP transduction system, associated with the cholinergic efferent innervation of the organ of Corti, is a feature that may he involved in some 
types of ototoxicity. The inefficiency of aminoglycosides and the putative targets of the ototoxic agents are discussed. 
Aminoglycosides; Cisplatin: Ethacrynate; Mercuric chloride: Inositol phosphates; Cochlear muscarinic receptors 
Introduction 
In the mammalian cochlea, the noxious effects of 
ototoxic substances are known to occur preferentially 
at two levels: the stria vascularis and the organ of Corti 
(for reviews see: Hawkins, 1976; Rybak, 1986; Huang 
and Schacht, 1989). In the latter structure, the outer 
hair cells (OHCs) are the main targets of the various 
drugs, such as aminoglycosidic antibiotics (Forge, 1985; 
Lenoir and Puel, 1987; Richardson and Russell, 19911, 
mercurials (Falk et al., 1974; Thalmann et al., 1977; 
Anniko and Sarkady, 1978) and cisplatin (an anti-cancer 
drug; Nakai et al., 1982; Barron and Daigneault, 1987; 
Laurel1 and Bagger-Sjbbgck, 1991). All these sub- 
stances, belonging to chemically unrelated groups, in- 
duce the degeneration of the OHCs. Their ototoxic 
actions are not, as yet, fully understood, and appear to 
be complex as revealed by the numerous effects in- 
duced by these molecules in the cochlea. Furthermore, 
the effects of the same class of drug can vary according 
to the stages of maturation, as indicated by the de- 
crease in the toxic potency of the aminoglycosides 
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observed during development (see for review Pujol, 
1986). 
In 1987, Williams and colleagues proposed a molec- 
ular model for the mechanism of aminoglycoside oto- 
toxicity. One step of this model is the interaction 
between the aminoglycosides and polyphosphoinosi- 
tides turnover (Orsulakova et al., 1976; Stockhorst and 
Schacht, 1977, Schacht, 1986) and this involves the 
binding of aminoglycosides to phosphatidylinositol 45 
biphosphate (PIP,; Lodhi et al.. 1976; Schacht, 1979, 
1986), the precursor of the second messengers inositol 
trisphosphates and diacylglycerol (Berridge and Irvine, 
1984; Nishizuka, 1984). Aminoglycoside binding re- 
duces the PIP, hydrolysis and would disturb the syn- 
thesis of IPs within the cochlea. In this organ, the IP 
signalling pathway may be associated with the motility 
of the OHCs (Schacht and Zenner, 1987) and has been 
demonstrated to be coupled to muscarinic acetyl- 
choline receptors (Guiramand et al., 199Ob; Niedzielski 
et al., 19921, which are probably of the M3 subtype 
(Guiramand et al., 1990b). Moreover, activation of 
these receptors results in an enhanced synthesis of IPs 
during the second and third weeks of post-natal devel- 
opment in the rat,‘with a peak of enhanced activity 
being found at post-natal day 12 (Bartolami et al., 
1990). This peak is concomitant with both the occur- 
rence of plastic events leading to efferent synaptogene- 
sis at the OHC level (Lenoir et al., 1980; Simmons et 
al., 1990; Cole and Robertson, 1992) and the period of 
increased susceptibility of OHCs to aminoglycoside-in- 
duced toxicity (see for review, Pujol, 1986). 
In view. of the interaction between the aminoglyco- 
sides and PIP, hydrolysis, that is associated with the 
cholinergic efferent system innervating the organ of 
Corti (Altschuler et al., 1985; Eybalin and Pujol, 1987; 
Dannhof et al., 1990, it is conceivable that a blockage 
of the IP transduction system could be a common 
factor underlying drug-induced ototoxicity. This pro- 
posal is also supported by the fact that the various 
ototoxic molecules induced some common molecular 
symptoms. For instance, the mechano-transduction 
channels of the frog vestibular hair cells are blocked by 
the aminoglycosides (Kroese et al., 19891, as are those 
of hair cells in the mouse organ of Corti (Richardson et 
al., 1989; K&s1 et al., 19901, and cisplatin has a similar 
effect (M&pine and Johnstone, 1990). Furthermore, 
aminoglycosides and cisplatin both suppress calcium 
influx into isolated OHCs, via voltage-gated calcium 
channels (Dulon et al., 1989; Saito et al., 1991). Physio- 
logically, ototoxic damage to the OHCs can be moni- 
tored by the inhibition of the cochlear microphonic. 
Such inhibition occurs following the application of 
aminoglycosides (Nuttall et al., 1977; Konishi, 1979; 
Takada and Schacht, 1982), cisplatin (Konishi et al., 
1983) and mercurials (Thalmann et al., 1977; Konishi 
and Hamrick, 1979). Finally, other ototoxic molecules, 
the ‘loop diuretics’, can enhance the damage induced 
by aminoglycosides (Russell et al., 1979; Hayashida et 
al., 1989) and cisplatin (Laurel1 and Engstriim, 1989; 
McAlpine and Johnstone, 1990). 
In order to assess the hypothesis that otoxic molecule 
other than aminoglycoside can interfere with the 
metabolism of IPs, we investigated the effects of five 
ototoxic molecules cisplatin, mercuric chloride, 
ethacrynate (a ‘loop’ diuretic), amikacin and neomycin 
(two aminoglycosides) on the synthesis of IPs that is 
stimulated by carbachol, a muscarinic preferring ago- 
nist, in 12-day-old rat cochleas. 
Materials and Methods 
Reagents 
Myo-[2-(3H)]-inositol (specific activity: 17.02 Ci per 
mmol) was purchased from Dositek (France) and 
trypsin from Gibco. Carbachol, amikacin sulphate, 
neomycin sulphate, ethacrynate, cisplatin (cis-diam- 
minedichloro platinum II) were obtained from Sigma. 
All other compounds were of analytical grade. 
Twelve-day-old Wistar rats were killed by quick 
cervical transection. The cochleas were rapidly dis- 
sected and collected in Krebs-Ringer buffer (con- 
ce~tration in FM: 125 NaCI, 3.5 KCl, 1.25 KHzPO,, 
1.2 MgSO,, 1.5 CaCl,, 25 NaHCO, and IO glucose). 
Throughout the experiment, the cochleas were main- 
tained in the Krebs-Ringer buffer, which was equili- 
brated to pH 7.4 by saturation with a gaseous mixture 
of 95% 0, and 5% CO, ~vol/vol). The dissected 
cochleas are composed of the organ of Corti, the spiral 
ganglion and the modiolus. These three parts were not 
used separately, but are a single unit of tissue. 
Label&g of the cochlear tissues 
3H-inositol inco~oration into the cochleas was car- 
ried out at 37*C, for 75 min in Krebs-Ringer buffer 
containing 1 PM cytidine and 10.8 pCi/ml of myo-[2- 
“HI-inositol. Labelling of the cochleas was achieved by 
using 89 ~1 of radioactive Krebs-Ringer buffer per 
cochlea. The cochleas were washed four times with 
Krebs-Ringer buffer and then individually distributed 
in plastic test tubes containing SO0 ~1 Krebs-Ringer 
buffer. The tubes were quickly transferred to a water 
bath with the temperature set at 37°C and continuously 
bubbled with the 95% 0,/5% CO, mixture. 
~ti~~atio~ ~nt~es~ of IPs and ~tracti~~ of the triti- 
ated IPs 
The toxic agents (where applicable) and LiCl (10 
mM) that blocks the IP cycle and therefore results in 
the accumulation of IPs (Berridge et al., 1982) were 
added to each tube, 15 min prior to stimulation by 
carbachol (1 mM). The muscarinic agonist was allowed 
to react for 20 min. The reaction was stopped by the 
application of 50 ~1 of perchloric acid (72%) per tube 
and by placing the tubes on ice. The cochleas were 
homogenised by sonication and the homogenates were 
centrifuged at 2000 x g for 5 min. The supernatants 
containing the “H-IPs were neutralised with 1.5 M 
KOH/0.075 M HEPES. After separation from “H-in- 
ositol and glycerophosphoinositols by anion-exchange 
chromatography, the 3H-IPs formed were measured in 
each cochlea as described previously (Guiramand et 
al., 199Ob). 
Assessment of cell death 
Cochleas that had been stimulated by 1 mM carba- 
chol (control) and cochleas that had been stimulated by 
1 mM carbachol after pre-treatment with either 
ethacrynate (1 mM) or cisplatin (1 mM> were taken at 
the end of the experiment (before the addition of the 
perchloric acid) and rinsed in Krebs-Ringer buffer. 
The organs of Corti were dissected and exposed to 
0.25% trypsin for 30 min at room temperature. Then 
they were washed in Krebs-Ringer buffer and mechani- 
cally dissociated with a Pasteur pipette. Trypan blue 
(0.04%) was added to each sample, The blue-stained 
dead cells and the unstained living cells were counted 
using a Malassez device. 
Data expression and statistical analysis 
The data are expressed as either percentages of the 
maximum level of accumulation of IPs induced by 
carbachol (1 mM1 or percentages of the control, basal 
level of synthesis of IPs. This basal level is expressed as 
the ratios of the “H-IPs (in dpm) accumulated to the 
amounts of dpm of ‘H-inositol taken up per cochlea 
(dpm ‘H-IPs/d pm ‘H-inositol). The amounts of dpm 
of ‘H-inositol taken up per cochlea is measured in the 
flow-through fraction of the anion exchanged chro- 
matography, as described elsewhere (Guiramand et al., 
1990b). All the data points are means + SEM of 6 
experiments, at least. The statistical significance of the 
data was determined using a two-tailed Student’s t-test. 
Results 
In non stimulated cochleas, the basal level of syn- 
thesis of IPs is 0.072 f 0.005 (f SEM) dpm “H- 
IPs/dpm “H-inositol, the addition of carbachol (1 mM) 
raises the IP response to 0.336 + 0.036 dpm “H- 
IPs/dpm “H-inositol. This rise correspond to an in- 
crease of 461 + 51% of the basal level. The application 
of mercuric chloride (Fig. 11, ethacrynate (Fig. 2) and 
cisplatin (Fig. 3) results in dose-dependent inhibition 
of the synthesis of IPs induced by carbachol (1 mM) in 
the 12-day-old rat cochlea. The IC,, values of 74 FM, 
0.34 mM and 0.43 mM are obtained for mercuric 
chloride, cisplatin and ethacrynate, respectively. This 
suggests the following relative order of efficacy: mer- 
curic chloride > cisplatin > ethacrynate. The inhibi- 
tions evoked by ethacrynate and cisplatin are very 
sharp, as indicated by the steep slopes of the dose-re- 
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sponse curves (Figs. 2 and 3), whereas the effect of 
mercuric chloride upon the stimulated IPs synthesis 
extends over 4 log units (Fig. 1). 
The maximum reductions in carbachol-enhanced 
formation of IPs are obtained with mercuric chloride at 
a concentration of 1 mM, ethacrynate at 1 mM and 
cisplatin at 0.4 mM. At these concentrations, the levels 
of formation of IPs obtained in the presence of carba- 
chol are 0.068 f 0.005, 0.063 _t 0.005 and 0.145 f 0.015 
dpm “H-IPs/dpm ‘H-inositol for mercuric chloride, 
700 
. clsplati~l/carbachol 
0 cisdotir L 
v-++mfJd 
ethacrynate and cisplatin, respectively. The measured 
responses do not extend above the control basal level 
in the cases of mercuric chloride (1 mM, Fig. 1) and 
ethacrynate (1 mM, Fig. 2). Both compounds behave 
therefore as full antagonist while cisplatin is a partial 
antagonist. 
In the absence of carbachol, mercuric chloride, at 10 
mM, reduces the synthesis of IPs by 54% (Fig. 1). On 
the other hand, ethacrynate and cisplatin, at concen- 
trations higher than 1 mM, significantly enhance the 
level of synthesis of IPs (Figs, 2 and 31, with levels of 
accumulation of IPs rising by 71% and 78% when 
cisplatin (2 mM) and ethacrynate (10 mM) are applied 
in the absence of carbachol (in both cases, P < 0.001). 
Due to the high concentrations of toxins that promote 
these changes of the non stimulated IP synthesis, these 
modifications have little pharmacological significance. 
The two aminoglycosides amikacin and neomycin 
were less efficient in changing the Ievels of basal or 
carbachol-stimulated synthesis of IPs than the other 
compounds. Indeed, the application of amikacin (1 
mM) and neomycin (1, 15 and 30 mM) do not alter the 
basal level of synthesis of IPs (data not shown). When 
the metabolism of IPs is subjected to muscarinic stimu- 
lation (carbachof, 1 mM), amikacin and neomycin, at 1 
mM, do not show any significant inhibitory effects (Fig. 
4). However, neomycin, at higher concentrations (15 
and 30 mM), is able to partially block the carbachol- 
stimulated synthesis of IPs (Fig. 4). At these concentra- 
tions, neomycin provokes, respectively, 29% and 43% 
inhibitions of the carbachol-elicited accumulation of 
IPs (P < 0.01). Experiments, using aminoglycoside at 
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high concentrations, were conducted only with neo- 
mycin, for it is the most toxic antibiotic, in term of 
interaction with the turnover of IPs, while amikacin is 
one of the least active (Wang et al., 1984; Schacht, 
1986). Since calcium and aminoglycosides compete to 
interact with the plasma membrane (Takada and 
Schacht, 1982), attempts to increase the neomycin- 
elicited blockage of the stimulated IPs response in- 
cluded omitting calcium from the reaction medium and 
the addition EGTA (0.1 mM) to the calcium free 
reaction medium. In both conditions~ no increase in 
the rate of inhibition is seen (Fig. 4). 
Tests of additivity of the effects of the otoxic sub- 
stances were achieved by using these drugs at concen- 
trations smaller than their respective IC,, (except for 
neomycin~. The results were compared to the theoreti- 
cal values of additivity. These theoretical vafues were 
calculated by subtracting, from the 100% Ievel, the 
sums of the individual levels of inhibition provoked by 
each individual drug, when applied on its own. The 
effects were additive with the following combinations: 
ethacrynate 0.3 m~/cispIatin 0.3 mM, ethacrynate 0.3 
mM/neomycin 15 mM, HgCI, 3 ~M/cisplatin 0.3 yM 
and HgCl, 3 FM/neomycin 15 PM (P < 0.01, Fig. 5) 
with the differences between the theoretical values of 
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additivity and the experimental data obtained when 
using those drug associations being smaller than the 
SEM of the experimental data. With the drug combina- 
tions ethacrynate 0.3 mM/HgCl, 3 PM and cisplatin 3 
mM/neomycin 15 PM the inhibitions of the 
carbachol-enhanced formation of IPs is less than theo- 
retical values of additivity (Fig. 5). 
In comparison to control, the amount of cell death 
in organs of Corti exposed either to cisplatin (1 mM) or 
to ethacrynate (1 mM) is not significantly different. 
Indeed, in untreated organs cell death is 46 + 18% 
while it amounts to 47 k 12% and 43 k 19% (+ SEM, 
in all case N = 3) in organs of Corti exposed to cis- 
platin and ethacrynate, respectively. 
Discussion 
We have previously shown that the muscarinic stim- 
ulation of the IP synthesis is maximum in the 12-day-old 
rat cochlea (Bartolami et al. 1990). At this age, the 
OHCs are particularly sensitive to aminoglycoside oto- 
toxicity (Pujol, 1986). Therefore we chose this develop- 
mental stage for the present study. 
Our data demonstrate the inhibitory effects of oto- 
toxic agents on the synthesis of the IP second messen- 
gers stimulated by a muscarinic agonist, in the 12-day- 
old rat cochlea. Similar suppressive actions by ototoxic 
drugs on carbachol-induced IP metabolism, in 8-day-old 
rat brain synaptoneurosomes (Guiramand et al., 1990a), 
reinforce our present findings. These authors sug- 
gested that the blockage of the agonist-activated 
turnover of IPs is likely to be due to a disturbance in 
the transduction system itself, rather than to a direct 
effect of the various ototoxic molecules on the brain 
muscarinic receptors. However, the results obtained 
here with the rat cochlea cannot provide any direct 
evidence for this hypothesis. The fact that the drugs 
only inhibit the carbachol-stimulated formation of IPs, 
and not the basal turnover of IPs at concentration of 
drugs below I mM, suggests that the cochlear mus- 
carinic receptors may be sensitive to the toxic agents. 
Also, one should point out that the molecular nature of 
the proteins involved in the signalling pathway may 
differ from the brain to the cochlea. 
Concerning ethacrynate and cisplatin, one could ar- 
gue that their inhibitory activity may be due to their 
cytotoxic properties. However this does not seem to be 
the case, firstly because cisplatin does not affect the 
viability of OHCs in vitro (Saito et al., 1991), and 
secondly in view of our results of the assessment of the 
overall cell survival in the organ of Corti. However, 
since the number of dead cells is fairly high, possibly as 
a result of the dissociation method used to count the 
cells, it is possible that restricted cell loss due to 
ethacrynate or cisplatin-induced cytotoxicity may be 
masked by the overall cell death. We cannot therefore 
state that cisplatin and ethacrynate are not cytotoxic in 
our model, but if a part of the inhibition of the IP 
responses is owed to cytotoxicity, this part would be 
very small and would appear when these toxins are 
used at high concentrations. 
Putatirle target proteins 
An obvious proposal could be that the inhibition of 
the IP signalling pathway is actually a common aspect 
of various toxic processes mediated by mercuric chlo- 
ride, ethacrynate, cisplatin and neomycin since the 
paired combinations of drugs are additive, apart from 
both ethacrynate/HgCl, and neomycin/cisplatin asso- 
ciations. However one cannot conclude that all these 
substances exactly interact with the same molecular 
target. Conversely, since the tested ototoxic molecules 
are not structurally related, several proteins and/or 
lipids are probably involved in interaction between the 
polyphosphoinositide transduction system and the toxic 
compounds. An indication in favour of such a diversity 
may be found in the shapes of the inhibition curves 
(Figs. 1, 2 and 3). Indeed, the slopes of these curves are 
much steeper in the case of ethacrynate and cisplatin 
than in the case of mercuric chloride. This suggests 
that both ethacrynate and cisplatin have a similar ef- 
fect on the carbachol-stimulated transduction system 
and mercuric chloride may be acting at several molecu- 
lar locations. 
In the cochlea, the carbachol-triggered IP synthesis 
presumably involves a number of different proteins 
each or all of which may be sensitive to acute applica- 
tion of the toxic agents. The first proteins to be acti- 
vated are the muscarinic receptors. The second ones 
may be the G proteins (guanine nucleotide binding 
proteins), of which the G,,, G, and G, types have been 
identified in the organ of Corti (Canlon et al., 1991; 
Koch and Gloddek, 1991). G,, and G, have been shown 
to interact in vitro with muscarinic receptors (Florio 
and Sternweis, 1985; Haga et al., 1986). Finally, the 
activity of phospholipase C that catalyses the hydrolysis 
of PIP, may also be reduced by the ototoxic substances 
such as aminoglycosides (Hostetler and Hall, 1982). 
The case of the aminoglycosides 
Unlike the other drugs, some aspects of the molecu- 
lar mechanism of the ototoxicity by the aminoglyco- 
sides are now well established (Schacht, 1986; Williams 
et al., 1987). This mechanism includes the binding of 
aminoglycosides with PIP, (Orsulakova et al., 1976; 
Stockhorst and Schacht, 1977; Schacht, 1979, 1986). 
This interaction may cause a decrease in the synthesis 
of IPs, in the cochlea, as suggested by the in vitro 
neomycin-mediated inhibition of brain PIP, hydrolysis 
by cochlear homogenates (Orsulakova et al., 1976). 
In the present report, however, the relative lack of 
effect of aminoglycosides on the carbachol-enhanced 
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IPs formation seems to be controversial with respect to 
the results reported by Orsulakova et al. (19761 where 
an inhibition of the PIP, hydrolysis was obtained by 
neomycin at a concentration of 0.5 mM, a concentra- 
tion less than the ones we used. The difference be- 
tween the results of Orsulakova et al. (19761 and ours 
may be partially explained by differences in the experi- 
mental models that could lead to variations in the 
sensitivity of the assays. For instance, we used whole, 
developing rat cochleas labelled with tritiated inositol, 
to measure the effects of ototoxic agents on the synthe- 
sis of IPs within the cochlea, whereas Orsulakova et al. 
examined the effects of neomycin on the hydrolysis of 
brain derived 32P-labelled PIP, by homogenates of 
organs of Corti dissected from adult guinea pigs. Com- 
parison of the results obtained with such different 
systems is difficult. However, one explanation could be 
that the duration of the neomycin exposure is not long 
enough to allow an appropriate penetration of the 
aminoglycoside into the target cells (Schacht, personal 
communication), hence this would not provide with an 
efficient neomycin-PIP2 binding (Schacht, 1986). 
Alternately, a possible cause for the absence of 
effect of aminoglycoside may be sought in the fact that 
aminoglycosides must be metabolised by enzymes, simi- 
lar to the ones found in the liver by Huang and Schacht 
(19901, in order to fully express their ototoxicity. Our in 
vitro assays may not provide with the physiological 
conditions necessary for the metabolism of the amino- 
glycosides. 
Takada and Schacht (1982) have shown that an 
increase in extracellular calcium can reverse the sup- 
pression of the cochlear microphonics by acute perfu- 
sion of gentamicin. Furthermore, taurine, an amino 
acid that decreases the calcium availability or sensitiv- 
ity (Huxtable, 19921, has been reported to potentiate 
the effects of neomycin (Kay and Davies, 1990). There- 
fore, the possibility that the relative inefficiency of 
~inoglycosides may be due to competition with cal- 
cium was assessed by depriving the medium of calcium 
(Fig 4). As no increase in the rate of inhibition was 
obtained in these conditions, calcium antagonism seems 
not to be involved here. It is likely that a 20-fold higher 
concentration of neomycin (30 mM neomycin/l.5 mM 
calcium) is large enough to efficiently displace the 
calcium from the membrane. 
Finally, the demonstrations that aminoglycosides can 
(1) modulate the GTPase activities in the human 
platelet membrane (Herrmann and Jakobs, 1988), (2) 
inhibit the lysosomal phospholipase C (Hostetler and 
Hall, 1982) in rat liver, (3) block the agonist stimulated 
turnover of IPs and protein kinase C translocation in 
renal cells (Ramsammy et al., 19881, indicate that 
aminoglycosides may not exclusively interact with 
pol~hosphoinositides but also with the proteins of the 
phosphoinositide signalling pathway. 
The possible involvement of’ reactive SH groups 
When attempting to ascribe some putative molecu- 
lar targets to the non-aminoglycoside ototoxic drugs, 
one can speculate that cisplatin and etha~~nate may 
block the G proteins coupled to phospholipase C. This 
is based on the finding that both these ototoxic sub- 
stances inhibit the G proteins associated with adeny- 
late cyclases in the guinea-pig cochlea (Koch and Glod- 
dek, 1991). In addition, ethacrynate-induced nephro- 
toxicity appears to involve an alkylating step (Koechet 
et al., 1984). Such a mechanism may also exist in 
ototoxicity. If this is proved to be true, the alkylated 
SH proteins would be some proteins of the transduc- 
tion system, including the muscarinic receptors and G 
proteins. Indeed, SH groups play a critical role in the 
regulation of the muscarinic receptors (Aronstam et 
al., 1978; Hedlund and Bartfai, 1979) and G proteins 
have three cysteines the alkylation of which decreases 
G protein activity (Winslow et al., 1987). Interaction 
with key SH groups may account for the effects of 
mercuric chloride too, since this compound is a well- 
known SH reagent (Vallee and Ulmer. 1972). In addi- 
tion, application of other alkylating substances, N-eth- 
ylmaleimide and cadmium chloride, have been demon- 
strated to block the carbachol-elicited IPs synthesis in 
the rat cochlea (Bartolami et al., 1992a,b). Finally, the 
~ssibiIi~ that cisplatin and the aminogly~osides may 
also interact with SH groups cannot be excluded since 
the reduced glutathione protects against the nephro- 
toxicity of cisplatin (Zunino et al., 1989) and also 
decreases the rate of OHCs death elicited by the 
cytotoxic metabolite of gentamicin (Garetz and Schacht, 
1992). 
Conclusion 
Altogether, the data presented indicate that the 
various different ototoxic molecules can reduce the 
level of IPs synthesis enhanced by an analog of the 
main efferent neurotransmitter, acetylcholine. In addi- 
tion, some of the ototoxic drugs can affect this 
metabolism in an additive way in the lZday-old rat 
cochlea. In view of the relatively high concentrations of 
ethacrynate that are required to block the carbachol- 
stimulated synthesis of IPs, it is unlikely that this is a 
mechanism contributing to the known ototoxicity of 
this drug observed in vivo, and the effects induced by 
both ethacrynate and mercuric chloride on the stria 
vascularis are more likely to be of greater importance. 
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